U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H11N3OS
Molecular Weight 245.3
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DACOPAFANT

SMILES

NC(=O)C1=C2CS[C@@H](N2C=C1)C3=CC=CN=C3

InChI

InChIKey=ARFOASMERCHFBY-GFCCVEGCSA-N
InChI=1S/C12H11N3OS/c13-11(16)9-3-5-15-10(9)7-17-12(15)8-2-1-4-14-6-8/h1-6,12H,7H2,(H2,13,16)/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C12H11N3OS
Molecular Weight 245.3
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Dacopafant (R-enantiomer RP 55778, racemate RP 48740) is an antagonist fo a platelet-activating factor and an inhibitor of TNH-alpha synthesis. It was developed by Rhone-Poulenc Rorer (France, now Aventis). In vitro, treatment of HIV-1 infected monocyte-derived macrophages with dacopafant resulted in a significant decrease in TNF-alpha levels and viral production. RP 48740 inhibited [3H]PAF platelet binding with IC50 of 2.3 uM and antagonized PAF-induced platelet activation with IC50 of 16 uM. In a clinical trial on human volunteers, RP 48740 was well tolerated and inhibited ex vivo platelet aggregation by as much as 79% 6 hr after administration.

Approval Year

PubMed

PubMed

TitleDatePubMed
Effects of RP 55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides.
1997 Apr
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:00:40 UTC 2023
Edited
by admin
on Sat Dec 16 17:00:40 UTC 2023
Record UNII
H1T03Z1G60
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DACOPAFANT
INN  
INN  
Official Name English
RP-55778
Code English
dacopafant [INN]
Common Name English
(3R)-3-(3-PYRIDYL)-1H,3H-PYRROLO(1,2-C)THIAZOLE-7-CARBOXAMIDE
Systematic Name English
RP-48740
Code English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
Code System Code Type Description
PUBCHEM
205955
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
EPA CompTox
DTXSID201176088
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
INN
6584
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
NCI_THESAURUS
C73132
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
CAS
125372-33-0
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
FDA UNII
H1T03Z1G60
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
ChEMBL
CHEMBL67588
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
EVMPD
SUB06886MIG
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
SMS_ID
100000083992
Created by admin on Sat Dec 16 17:00:40 UTC 2023 , Edited by admin on Sat Dec 16 17:00:40 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY